Several studies have shown that aberrant activation of SRC or other SFK members promotes tumorigenesis in esophageal (ESCC), head and neck (HNSCC) and lung squamous cell carcinomas (LSCC) (5, 12, 13). Here, SRC is linked to head and neck squamous cell carcinoma.